Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
13
×
drugs
13
×
fda
13
×
life sciences
national blog main
clinical trials
san francisco blog main
san francisco top stories
boston blog main
national top stories
new york blog main
san diego blog main
san diego top stories
boston top stories
new york top stories
startups
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
detroit blog main
detroit top stories
investing
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
astrazeneca
deals
eli lilly
medical device
teva pharmaceutical
boston
cancer
cystic fibrosis
What
fda
drug
drugs
bio
biological
cells
company
medicines
roundup
therapies
approval
approved
available
biologics
can’t
class
clears
companies
convenience
decades
decision
digestive
disease
enzymes
humans
hurdle
make
medicine
migraine
new
pill
produce
products
proteins
rani’s
robotic
survive
swallowing
that’s
treatment
Language
unknown
Current search:
fda
×
biotech
×
drugs
×
@xconomy.com
4 years ago
Jeff Leiden, Who Shaped Vertex Into a CF Force, to Switch Roles
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Rani’s “Robotic Pill” for Biologics Clears First Hurdle in Humans
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing